Drugs Made In America Acquisition (DMAA) Competitors $10.27 -0.01 (-0.10%) As of 08/15/2025 03:56 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOwnershipSEC FilingsTrendsBuy This Stock DMAA vs. SAFE, SBR, DEA, UNIT, CSR, ORC, FBRT, PAX, NXRT, and NOAHShould you be buying Drugs Made In America Acquisition stock or one of its competitors? The main competitors of Drugs Made In America Acquisition include Safehold (SAFE), Sabine Royalty Trust (SBR), Easterly Government Properties (DEA), Uniti Group (UNIT), Centerspace (CSR), Orchid Island Capital (ORC), Franklin BSP Realty Trust (FBRT), Patria Investments (PAX), NexPoint Residential Trust (NXRT), and Noah (NOAH). These companies are all part of the "trading" industry. Drugs Made In America Acquisition vs. Its Competitors Safehold Sabine Royalty Trust Easterly Government Properties Uniti Group Centerspace Orchid Island Capital Franklin BSP Realty Trust Patria Investments NexPoint Residential Trust Noah Drugs Made In America Acquisition (NASDAQ:DMAA) and Safehold (NYSE:SAFE) are both small-cap trading companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations. Do insiders & institutionals hold more shares of DMAA or SAFE? 70.4% of Safehold shares are owned by institutional investors. 3.5% of Safehold shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is DMAA or SAFE more profitable? Safehold has a net margin of 27.45% compared to Drugs Made In America Acquisition's net margin of 0.00%. Safehold's return on equity of 4.70% beat Drugs Made In America Acquisition's return on equity.Company Net Margins Return on Equity Return on Assets Drugs Made In America AcquisitionN/A N/A N/A Safehold 27.45%4.70%1.61% Which has better valuation & earnings, DMAA or SAFE? Safehold has higher revenue and earnings than Drugs Made In America Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDrugs Made In America AcquisitionN/AN/AN/AN/AN/ASafehold$374.10M2.93$105.76M$1.4310.66 Does the media prefer DMAA or SAFE? In the previous week, Safehold had 3 more articles in the media than Drugs Made In America Acquisition. MarketBeat recorded 5 mentions for Safehold and 2 mentions for Drugs Made In America Acquisition. Drugs Made In America Acquisition's average media sentiment score of 1.88 beat Safehold's score of 0.52 indicating that Drugs Made In America Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Drugs Made In America Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Safehold 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts prefer DMAA or SAFE? Safehold has a consensus price target of $21.89, suggesting a potential upside of 43.53%. Given Safehold's stronger consensus rating and higher possible upside, analysts plainly believe Safehold is more favorable than Drugs Made In America Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Drugs Made In America Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Safehold 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44 SummarySafehold beats Drugs Made In America Acquisition on 10 of the 11 factors compared between the two stocks. Get Drugs Made In America Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for DMAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DMAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DMAA vs. The Competition Export to ExcelMetricDrugs Made In America AcquisitionInvestment Offices IndustryFinancial SectorNASDAQ ExchangeMarket Cap$299.88M$178.79M$6.42B$9.82BDividend YieldN/AN/A4.17%4.07%P/E RatioN/AN/A14.2125.13Price / SalesN/AN/A1,858.97115.19Price / CashN/A36,712.32127.1259.05Price / BookN/AN/A5.216.18Net IncomeN/A-$160K$1.23B$265.11M7 Day Performance0.10%0.22%0.74%4.20%1 Month PerformanceN/A0.04%2.29%1.99%1 Year PerformanceN/A6.57%26.66%23.75% Drugs Made In America Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DMAADrugs Made In America AcquisitionN/A$10.27-0.1%N/AN/A$299.88MN/A0.002Positive NewsSAFESafehold4.3141 of 5 stars$15.51+0.8%$21.89+41.1%-35.7%$1.11B$365.68M10.85120Analyst ForecastHigh Trading VolumeSBRSabine Royalty Trust2.6721 of 5 stars$71.52-0.2%N/A+14.6%$1.04B$83.17M14.192,020Positive NewsEarnings ReportDividend IncreaseDEAEasterly Government Properties2.755 of 5 stars$22.22-0.5%$27.15+22.2%-34.4%$1.01B$302.05M54.1850Positive NewsUNITUniti Group1.5482 of 5 stars$6.43-4.7%$6.70+4.2%+55.7%$951.51M$1.17B23.37750Short Interest ↓CSRCenterspace4.2064 of 5 stars$55.01-1.8%$69.75+26.8%-25.0%$922.02M$260.98M-30.56470Positive NewsORCOrchid Island Capital2.5562 of 5 stars$7.15-0.2%N/A-11.4%$905.49M$241.58M35.732,018Dividend AnnouncementShort Interest ↑FBRTFranklin BSP Realty Trust4.2278 of 5 stars$11.01-1.4%$14.88+35.2%-12.9%$905.44M$516.24M11.23N/APAXPatria Investments2.8316 of 5 stars$13.78-0.9%$14.00+1.6%+14.6%$835.63M$397.50M27.56390NXRTNexPoint Residential Trust4.2854 of 5 stars$31.16-1.7%$41.50+33.2%-30.5%$790.29M$259.70M-15.903Analyst ForecastNOAHNoah4.154 of 5 stars$11.89+1.1%$12.00+0.9%+50.8%$786.64M$356.33M12.261,990Positive News Related Companies and Tools Related Companies SAFE Alternatives SBR Alternatives DEA Alternatives UNIT Alternatives CSR Alternatives ORC Alternatives FBRT Alternatives PAX Alternatives NXRT Alternatives NOAH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DMAA) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredJPMorgan: Gold to $4,250—Here’s the Real PlayGold Surges And Some Investors Are Getting Paid, But Most Are Not. Which One Do You Want to Be? Gold prices ar...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access